RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test
At DNA Labs UAE, we offer the RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test. This test is designed to diagnose and provide valuable information about Minicore myopathy with external ophthalmoplegia, a genetic disorder characterized by muscle weakness and wasting (myopathy) and weakness or paralysis of the muscles that control eye movement (external ophthalmoplegia).
Test Components
The RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test includes the following components:
- NGS Technology
- Neurological Disorders Test Type
- Genetics Test Department
Price
The cost of the RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test is 4400.0 AED.
Sample Condition
The test can be performed using the following sample conditions:
- Blood
- Extracted DNA
- One drop of blood on FTA Card
Report Delivery
The report for the RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test will be delivered within 3 to 4 weeks.
Method
The RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test utilizes NGS (Next-Generation Sequencing) technology. This advanced sequencing technology allows for the simultaneous analysis of multiple genes, including the RYR1 gene. It identifies changes or mutations in the DNA sequence of the genes being analyzed.
Test Type
The RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test is specifically designed for diagnosing neurological disorders.
Doctor
The RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test is recommended to be performed by a Neurologist.
Test Department
The RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test is conducted in the Genetics Test Department.
Pre Test Information
Prior to undergoing the RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with RYR1 Gene Minicore Myopathy with External Ophthalmoplegia.
About RYR1 Gene Minicore Myopathy with External Ophthalmoplegia
The RYR1 gene is associated with a condition called Minicore myopathy with external ophthalmoplegia. This genetic disorder is characterized by muscle weakness and wasting (myopathy) and weakness or paralysis of the muscles that control eye movement (external ophthalmoplegia).
NGS genetic testing, such as the RYR1 Gene Minicore Myopathy with External Ophthalmoplegia Genetic Test, allows doctors and geneticists to identify specific mutations or changes in the RYR1 gene. This information aids in the diagnosis of Minicore myopathy with external ophthalmoplegia, predicts disease progression, and guides treatment decisions.
Test Name | RYR1 Gene Minicore myopathy with external ophthalmoplegia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for RYR1 Gene Minicore myopathy with external ophthalmoplegia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RYR1 Gene Minicore myopathy with external ophthalmoplegia |
Test Details |
The RYR1 gene is associated with a condition called Minicore myopathy with external ophthalmoplegia. This is a genetic disorder characterized by muscle weakness and wasting (myopathy) and weakness or paralysis of the muscles that control eye movement (external ophthalmoplegia). NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the RYR1 gene. It uses advanced sequencing technology to identify changes or mutations in the DNA sequence of the genes being analyzed. By performing NGS genetic testing on the RYR1 gene, doctors and geneticists can identify specific mutations or changes in the gene that are associated with Minicore myopathy with external ophthalmoplegia. This information can help in diagnosing the condition, predicting disease progression, and guiding treatment decisions. |